Polaris News

QC Designs a Different Molecule
Drug discovery is a complicated process of identifying a small molecule that can bind to a specific protein pocket and change disease progression by blocking (or enhancing) the activity of that protein. Not only does it have to interact with the protein in a favorable manner, but it also must have the properties that make…
Read more
POLARISqb and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AI
Auransa, Inc.,an AI biotech and Polaris Quantum Biotech (Polarisqb), a quantum based drug design company, announce progress on important breast cancer target. PALO ALTO, CA, DURHAM, NC, USA, August 9, 2022 /EINPresswire.com/ -- Auransa, Inc., an artificial intelligence (AI) company developing precision medicines in areas of unmet medical needs, and Polaris Quantum Biotech (Polarisqb), a…
Read more
POLARISqb is Hiring! Junior Sales Executive
Polaris Quantum Biotech is a revolutionary startup that uses Quantum Computing, AI/ML, and Computational Chemistry to design novel drug leads for multiple diseases. We are seeking to hire an ambitious, highly driven, and goal-oriented Junior Sales/Account Manager with enthusiasm for revolutionizing drug discovery. PolarisQB headquarters are located in the Research Triangle Park, however, this position…
Read more
Dr. Ken Byler: Drug Discovery from the Jungle to the Quantum Computer
On the back porch of a botanist’s home in the mountains of Costa Rica in 1992, a group of chemists worked diligently, isolating and testing natural products from samples collected in the cloud rainforest, searching for potential cures for diseases. Amongst them was a young Ken Byler, a student who wanted to be a doctor…
Read more